CN106011158A - Method using microorganism method to convert androstenedione so as to produce testosterone - Google Patents
Method using microorganism method to convert androstenedione so as to produce testosterone Download PDFInfo
- Publication number
- CN106011158A CN106011158A CN201610575007.5A CN201610575007A CN106011158A CN 106011158 A CN106011158 A CN 106011158A CN 201610575007 A CN201610575007 A CN 201610575007A CN 106011158 A CN106011158 A CN 106011158A
- Authority
- CN
- China
- Prior art keywords
- testosterone
- androstenedione
- enzyme
- hsd3
- conversion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 title claims abstract description 78
- 229960003604 testosterone Drugs 0.000 title claims abstract description 39
- AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 title claims abstract description 28
- 229960005471 androstenedione Drugs 0.000 title claims abstract description 28
- AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title abstract description 23
- 244000005700 microbiome Species 0.000 title abstract description 5
- 108090000790 Enzymes Proteins 0.000 claims abstract description 38
- 102000004190 Enzymes Human genes 0.000 claims abstract description 38
- 241000235015 Yarrowia lipolytica Species 0.000 claims abstract description 16
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims abstract description 14
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims abstract description 7
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 claims description 18
- 239000013612 plasmid Substances 0.000 claims description 17
- 230000015572 biosynthetic process Effects 0.000 claims description 10
- 238000003786 synthesis reaction Methods 0.000 claims description 10
- 108010070743 3(or 17)-beta-hydroxysteroid dehydrogenase Proteins 0.000 claims description 3
- 230000009466 transformation Effects 0.000 claims description 3
- 108020004705 Codon Proteins 0.000 claims description 2
- 108010020056 Hydrogenase Proteins 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 19
- 238000004519 manufacturing process Methods 0.000 abstract description 15
- 239000000758 substrate Substances 0.000 abstract description 12
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 abstract description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 6
- 238000010353 genetic engineering Methods 0.000 abstract description 6
- 239000005515 coenzyme Substances 0.000 abstract description 5
- 239000002028 Biomass Substances 0.000 abstract description 3
- 229920000858 Cyclodextrin Polymers 0.000 abstract description 3
- 239000006184 cosolvent Substances 0.000 abstract description 3
- 238000011160 research Methods 0.000 abstract description 2
- 101710088194 Dehydrogenase Proteins 0.000 abstract 1
- 239000001116 FEMA 4028 Substances 0.000 abstract 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 abstract 1
- 229960004853 betadex Drugs 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 230000001580 bacterial effect Effects 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- 108010084625 17-beta-hydroxysteroid dehydrogenase type 3 Proteins 0.000 description 11
- 102100022585 17-beta-hydroxysteroid dehydrogenase type 3 Human genes 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 9
- 238000001514 detection method Methods 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 8
- 230000004151 fermentation Effects 0.000 description 8
- 230000000284 resting effect Effects 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 150000003431 steroids Chemical class 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 101150019455 gdh gene Proteins 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 108010029645 galactitol 2-dehydrogenase Proteins 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 239000012064 sodium phosphate buffer Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 102100034067 Dehydrogenase/reductase SDR family member 11 Human genes 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 241000235061 Pichia sp. Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000006052 feed supplement Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 239000000745 gonadal hormone Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 210000002570 interstitial cell Anatomy 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 230000000920 spermatogeneic effect Effects 0.000 description 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- YZOUYRAONFXZSI-SBHWVFSVSA-N (1S,3R,5R,6R,8R,10R,11R,13R,15R,16R,18R,20R,21R,23R,25R,26R,28R,30R,31S,33R,35R,36R,37S,38R,39S,40R,41S,42R,43S,44R,45S,46R,47S,48R,49S)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-37,39,40,41,42,43,44,45,46,47,48,49-dodecamethoxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,38-diol Chemical group O([C@@H]([C@H]([C@@H]1OC)OC)O[C@H]2[C@@H](O)[C@@H]([C@@H](O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3O)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O3)O[C@@H]2CO)OC)[C@H](CO)[C@H]1O[C@@H]1[C@@H](OC)[C@H](OC)[C@H]3[C@@H](CO)O1 YZOUYRAONFXZSI-SBHWVFSVSA-N 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- 101150028469 G6PDH gene Proteins 0.000 description 1
- 101150063795 HSD3 gene Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 1
- 101150085516 ZWF1 gene Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003263 anabolic agent Substances 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 102000001307 androgen receptors Human genes 0.000 description 1
- 108010080146 androgen receptors Proteins 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000703 anti-shock Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- MWKXCSMICWVRGW-UHFFFAOYSA-N calcium;phosphane Chemical compound P.[Ca] MWKXCSMICWVRGW-UHFFFAOYSA-N 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000012824 chemical production Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000010437 erythropoiesis Effects 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- XUWPJKDMEZSVTP-LTYMHZPRSA-N kalafungina Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1[C@@H](C)O[C@H]1[C@@H]2OC(=O)C1 XUWPJKDMEZSVTP-LTYMHZPRSA-N 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000002863 seminiferous tubule Anatomy 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- -1 steroid compound Chemical class 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01051—3 (or 17)-Beta-hydroxysteroid dehydrogenase (1.1.1.51)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/99—Oxidoreductases acting on the CH-OH group of donors (1.1) with other acceptors (1.1.99)
- C12Y101/9901—Glucose dehydrogenase (acceptor) (1.1.99.10)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/102—Plasmid DNA for yeast
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention relates to a method recombining Yarrowia lipolytica to efficiently and biologically convert androstenedione so as to produce testosterone and belongs to the field of genetic engineering. The method is characterized in that 17beta-hydroxyl steroid dehydrogenase from human and glucose dehydrogenase from saccharomyces cerevisiae are respectively cloned and excessively co-expressed in Y.lipolytica Polh, and the androstenedione is efficiently converted in the Yarrowia lipolytica to produce the testosterone for the first time at home and abroad by building an NADPH coenzyme circulation system. The enzyme activity determination and intracellular coenzyme level researches of the built genetic-engineering strains show that the recombinant strains can continuously and effectively convert the androstenedione to produce the testosterone. When the conversion temperature is 37 DEG C, conversion pH is 7.5, substrate cosolvent is methylated-beta-cyclodextrin, biomass is 200g/L and substrate concentration is 5g/L, 15g/L androstenedione is converted into 14.3g/L testosterone after three material-supplementing whole-cell conversions, the currently-reported highest level of testosterone production using microorganism conversion is achieved, and a foundation is provided for industrial testosterone production using microorganisms.
Description
Technical field
A kind of bioconversion ANDROSTENEDIONE produces the method for testosterone, belongs to genetic engineering and enzyme engineering field.
Background technology
Steroid drugs can be obtained by complete synthesis or to the degraded of natural steroid compound and its functional group conversion, and steroid drugs has
There are the pharmacological actions such as the strongest infection, Gang Guomin, antiviral and shock.Along with the development in epoch, steroid drugs is
Through becoming the second largest class medicine being only second to antibiotic, within 2000, steroid drugs has broken through 200 in the sales volume of whole world pharmaceutical market
Hundred million dollars, account for the 6% of world's medicine total sales volume.
Steroid hormone class classification of drug: adrenocortical hormone, including hydrocortisone, prednisone etc..A Disenshi can be treated
Disease, antiinflammatory, antiallergic, antishock etc.;Protein anabolic hormone, its main Physiological Function is suppression albumen alienation and promotes egg
White synthesis, is mainly used in treating the disease that protein increases and synthesis deficiency causes;Gonadal hormone, including estrogen, male swash
Element and progestogen.
The raw material of synthesizing steroid medicine extracting directly from animal tissue's liquid mostly in early days, owing to the content of these raw materials is low, source
Less, complex synthetic route, the response rate are low, of a high price, it is impossible to meet the needs of production.The discovery of diosgenin and application,
Industrialized production for steroid drugs provides abundant and cheap raw material, but production process needs to consume substantial amounts of Rhizoma Dioscoreae soap
Element, makes Saponin price constantly rise, and adds production cost, and production process serious environment pollution.
Testosterone is the androgen produced by interstitial cell, and testosterone mainly has following aspect effect: 1. maintain Spermatogenic action, testosterone
After Interstitial cell is secreted, can be through supporting that cell enters convoluted seminiferous tubule, testosterone can directly or first be changed into the dihydrotestosterone that activity is higher,
Be combined with the androgen receptor of spermatogenic cell, promote the generation of sperm.2. stimulate the growth promoter of genitals, promote that male is secondary
Levy appearance and maintain its normal condition;3. normal libido is maintained;4. the egg of protein synthesis, particularly muscle and genitals is promoted
White matter synthesizes, and can also promote bone growth and calcium phosphorus precipitation and erythropoiesis etc. simultaneously.
17beta-Hydroxysteroid dehydrogenase (17 β-hydroxysteroid dehydrogenase, 17 β-HSD) is in gonadal hormone building-up process
The catalyzing enzyme of final step.Its catalytic swashs the reduction between the ketone group on C17 position and alcohol radical and oxidation reaction, makes low biological alive
Mutually convert between the estradiol of estrone, androstenedione and high bioactivity of property, testosterone.Derive from human body testis
17 β-HSD3, it is possible to narrow spectrum catalysis ANDROSTENEDIONE (AD) synthesis testosterone (TS), it, as one detection enzyme, is applied to
Medical treatment detection field.Meanwhile, have, at aspects such as food development, health care, clinical monitoring, biological pesticides, the valency that is widely used
Value.17 β-HSD are furtherd investigate the development to whole steroid drugs industry of far-reaching significance.Produce the testosterone of more high added value
The most effective method is exactly with ANDROSTENEDIONE as substrate, is converted by microorganism one step.
The present invention passes through plasmid pINA1292 and pYLSC, it is achieved that derive from people's and saccharomyces cerevisiae 17 β-hsd3 and gdh
Gene solubility overexpression in Yarrowia lipolytica Polh, enzyme is alive respectively reaches 7.35U/mg and 4.23U/mg,
15g/L AD is converted and produces 14.3g/L TS by 5L fermentation tank current adding substrate resting cell AD, 120h.Derive from people's
17 β-HSD3 express in Yarrowia lipolytica system, and NADPH coenzyme circular regeneration system and resting cell AD are
Reported first, and the enzyme conversion ratio alive and AD that recombinant bacterium is expressed is the highest.Yarrowia lipolytica is as the industry of safety and stability
Producing bacterial strain, condition of culture is simple, and fermentation period is short, becomes microorganism sterol fermentation industry potential production bacterial strain.
Summary of the invention
It is an object of the invention to provide: obtained micro-life with resting cell production TS ability by genetic engineering means
The method of thing.The recombinant bacterial strain built is carried out enzyme activity and fermenting property carries out research and finds 17 β-HSD3 and GDH enzyme activity
All improve a lot, and obtained higher conversion ratio.For the guidance that the industrialization offer of fermentable production TS is useful.
Technical scheme: be to build a strain resting cell cholesterol with genetic engineering for means to generate the restructuring solution of TS
Fat Ye Shi yeast strain, with HPLC for the generation of product in method detection fermentation liquid, screens positive recombinant, passes through enzyme activity
Detection with fermenting property determines vigor and the substrate conversion efficiency of its target enzyme.The present invention successfully constructs a strain with AD as the end
Thing resting cell is the Yarrowia lipolytica engineered strain of the high yield TS of method, its 17 β-HSD3 and GDH enzyme activity and the end
Thing conversion ratio relatively starting strain improves a lot.
Main agents: AD and TS is purchased from SIGMA company of the U.S.
Recombinant bacterial strain construction method:
(1) 17 β-HSD3 and the clone of GDH gene complete sequence
The SD sequence (GI:21706851) of the 17 β-HSD3 of the people according to the announcement of GENBANK website and the GDH of saccharomyces cerevisiae
Gene complete sequence, first pass around codon optimized after, respectively with on pINA1292 and pYLSC plasmid restriction enzyme site design
17 β-hsd3 and gdh gene primer.With the DNA of total gene synthesis as template, amplify 17 β-hsd3 and ZWF1 by PCR
Complete sequence.
PCR reaction system: 10 × ExTaq Buffer 5 μ L, dNTP 4 μ L, template DNA 1 μ L, each 0.5 μ L of upstream and downstream primer,
ExTaq enzyme 1 μ L, ddH2O polishing is to cumulative volume 50 μ L.PCR reaction condition: 94 DEG C of 5min, 94 DEG C of 30s, 65 DEG C
45s, 72 DEG C of 2min, circulate 35 times, 72 DEG C of 10min, 12 DEG C of 10min.
(2) structure of recombinant expression carrier pINA1292-17 β-hsd3 and pYLSC-gdh
Reclaim test kit description with reference to Shanghai JaRa company glue and reclaim PCR primer, glue reclaim product by a certain percentage with
PMD18-T vector overnight connects, Transformed E .coli JM109 competent cell, uses amicillin resistance plate screening weight
Group bacterium, recombiant plasmid discharges size respectively through BamH I/Nde I enzyme action and is about 2.7kb and 1.0kb and 2.7kb and 1.5kb
Gene band, show construction of recombinant plasmid success, recombiant plasmid named pMD18-T-17 β-hsd3 and pMD18-T-gdh.
Extract plasmid pINA1292, pYLSC, pMD18-T-17 β-hsd3 of being stored in E.coli JM109 and
PMD18-T-gdh, plasmid pINA1292 and pMD18-T-17 β-hsd3 and pYLSC and pMD18-T-gdh are respectively through BamH
I/Not I and BstBI/XhoI double digestion, glue reclaims purification, T4DNA ligase overnight connects two fragments, will connect the most afterwards
Thing thermal shock Transformed E .coli JM109 competent cell, uses kalamycin resistance plate screening positive transformant.Extract transformant
Plasmid, recombiant plasmid discharges size respectively after BamH I/Not I and BstBI/XhoI double digestion respectively and is about 9.0kb and 1.0
The genetic fragment of kb and 3.6kb and 1.5kb, it was demonstrated that construction of recombinant plasmid success, recombiant plasmid named pINA1292-17 β-hsd3
And pYLSC-gdh.
(3) recombiant plasmid pINA1292-17 β-hsd3 and pYLSC-gdh electrotransformation convert bacterial strain Yarrowia lipolytica Polh
The recombiant plasmid pINA1292-17 β-hsd3 and pYLSC-gdh empirical tests successfully constructed is taken up in order of priority and turns with electrotransformation
Change and express to type strain Y.lipolytica Polh.
(4) screening of recombinant bacterial strain Y.lipolytica Polh positive transformant;
Picking has the bacterium colony grown on YPD and hygromycin pressure flat, shake-flask culture, extracts chromosome and carries out PCR checking.
(5) restructuring Y.lipolytica Polh condition of culture, enzyme activity determination and HPLC analyze
Condition of culture: LB culture medium: cholesterol 1g/L, glucose 10g/L, peptone 10g/l, yeast extract 5g/L, NaCl
10g/L (solid medium adds 2% agar powder)
Flat board MD culture medium (g/L): yeast basic nitrogen source (YNB) 13.4, biotin 4 × 10-4, glucose 20, agar 15;
YPD culture medium (g/L): peptone 20, glucose 20, yeast powder 10, at YPD when being used for screening G418 resistance
Solid medium adds the G418 of desired concn and i.e. obtains YPD/G418 flat board, at YPD solid when being used for screening hygromycin resistance
Culture medium adds the hygromycin of desired concn and i.e. obtains YPD/HygB flat board;
Buffered Minimal Glycerol-complex Medium (BMGY) culture medium (g/L): YNB 13.4, glycerol 10,
Biotin 4 × 10-4, constant volume uses 0.1mol/L kaliumphosphate buffer (pH 6.0);
Buffered Minimal Methanol Medium (BMMY) culture medium (g/L): methanol 20, biotin 4 × 10-4, YNB
13.4, constant volume uses 0.1mol/L kaliumphosphate buffer (pH 6.0);
Enzyme activity determination method: use HPLC method to measure.Concrete grammar is as follows: take cultivate 24h bacterium solution 50mL, 4 DEG C,
8,000r/min are centrifuged 5min collects thalline, with the Tris-HCl buffer solution twice of 50mL pH 7.0, is resuspended in 5ml
This buffer in.In ice bath, 40% power ultrasonic crushes, work 2s interval 5s, working time 10min.10,000r/min
Centrifugal 30min obtains supernatant, is destination protein in supernatant.Enzyme activity determination method is as follows: enzyme activity determination system 1mL
Including 0.5mM NADPH, 200 μMs of AD (being dissolved in methanol), add appropriate enzyme liquid.Enzyme activity unit defines: 37 DEG C of temperature
Under degree, 1min converts the enzyme amount of 1 μm ol AD generation TS and is defined as 1 enzyme unit (U) alive.G-6-P dehydrogenation
Enzyme activity determination method: 1mL reaction system includes 50mM sodium phosphate buffer (pH 6.5), 10mM G-6-P
With 1 μM of NADP+.According to the change detection vigor of NADPH light absorption value under 340nm, enzyme unit definition alive: per minute
Produce the enzyme amount required for 1 μm ol NADPH.Glucose dehydrogenase vigour-testing method: 1mL reaction system includes 50mM
Sodium phosphate buffer (pH 6.5), 10mM glucose and 1 μM of NADP+.According to NADPH light absorption value under 340nm
Change detection vigor, enzyme unit definition alive: the enzyme amount required for generation 1 μm ol NADPH per minute.
HPLC analyzes: AD and TS all has characteristic absorption peak under 240nm ultraviolet wavelength, so using HPLC method to measure
Production concentration.Chromatographic condition: chromatographic column: DimosoilC18(5 μ l, 250mm × 4.6mm), flow phase: acetonitrile-water (V/V=85:15),
Detector: UV Detector, detects wavelength: 210nm, column temperature: 30 DEG C, sample size: 10 μ L, flow velocity: 1.0ml/min.
Beneficial effects of the present invention: expand 17 complete synthesis β-HSD3 and GDH gene by genetic engineering means, by this reality
Test the Yarrowia lipolytica expression system of the existing maturation in room, it is achieved that 17 β-HSD3 and G6PDH gene are at type strain Y.
Overexpression in lipolytica Polh.This bacterial strain is inoculated in 100mL BMGY culture medium with 5% inoculum concentration, cultivates
24h, is then inoculated in the 5L fermentation tank equipped with 2L BMMY culture medium with 5% inoculum concentration, persistently adds methanol and lures
Lead 4 days.Bacteria recovered by centrifugation, washes twice, and redissolves with Tris-HCl pH 7.5 buffer of a certain amount of 50mM, adds
Substrate A D converts, and conversion condition is: conversion temperature is 37 DEG C, convert pH be 7.5, substrate cosolvent for the-β that methylates-
Cyclodextrin (molar ratio is 1:1), Biomass is 200g/L, and concentration of substrate is 5g/L.After 3 feed supplement resting cells,
15g/L ANDROSTENEDIONE is converted into 14.3g/L testosterone, builds NADPH coenzyme indirect regeneration for domestic and international first passage
ANDROSTENEDIONE production of testosterone by conversion is utilized, the final purpose realizing improving conversion rate, efficiently production testosterone in Pichia sp..
Substrate A D mono-step changes into the TS with more high additive value, and it has important physiology and medicine effect, is simultaneously
Important medicine intermediate;Producing TS with microbial method, it has reaction condition gentleness, raw material availability than chemical production method
The advantage, the most beneficially environmental conservation such as high, product purity high and technique is simple, easily controllable, it is easy to popularization and application.
Accompanying drawing explanation
Nothing
Detailed description of the invention
Embodiment 1: the structure of restructuring Y.lipolytica Polh bacterial strain
With the complete synthesis gene of laboratory as template, utilize PCR means to obtain the gene of this enzyme, connect cloning vehicle, it is achieved base
A large amount of amplifications of cause.By the 17 β-hsd3 expanded in a large number and gdh genetic fragment, be connected respectively to after purification pINA1292 and
On pYLSC carrier, after being proved to be successful, transformation mode bacterial strain Y.lipolytica Polh.Resistant panel is screened positive transformant,
Inoculation shake flask fermentation, with product TS in HPLC detection fermentation liquid.Product TS detected, illustrate to have successfully constructed have turn
Changing AD is the recombinant bacterial strain of TS.The present invention finally gives has the Y.lipolytica Polh bacterial strain that Efficient Conversion AD is TS.
Embodiment 2: the enzyme activity determination of recombinant bacterial strain
Enzyme activity determination method: use HPLC method to measure.Concrete grammar is as follows: take cultivate 24h bacterium solution 50mL, 4 DEG C,
8,000r/min are centrifuged 5min collects thalline, with the Tris-HCl buffer solution twice of 50mL pH 7.0, is resuspended in 5ml
This buffer in.In ice bath, 40% power ultrasonic crushes, work 2s interval 5s, working time 10min.10,000r/min
Centrifugal 30min obtains supernatant, is destination protein in supernatant.Enzyme activity determination method is as follows: enzyme activity determination system 1mL
Including 0.5mM NADPH, 200 μMs of AD (being dissolved in methanol), add appropriate enzyme liquid.Enzyme activity unit defines: 37 DEG C of temperature
Under degree, 1min converts the enzyme amount of 1 μm ol AD generation TS and is defined as 1 enzyme unit (U) alive.Glucose dehydrogenase vigor
Assay method: 1mL reaction system includes 50mM sodium phosphate buffer (pH 6.5), 10mM glucose and 1 μM of NADP+。
According to the change detection vigor of NADPH light absorption value under 340nm, enzyme unit definition alive: generation 1 μm ol NADPH per minute
Required enzyme amount.Enzyme is lived and is respectively reached 7.35U/mg and 4.23U/mg.
Embodiment 3: recombinant bacterial strain resting cell performance detects
This bacterial strain is inoculated in 100mL BMGY culture medium with 5% inoculum concentration, cultivates 24h, then connect with 5% inoculum concentration
Plant in the 5L fermentation tank equipped with 2L BMMY culture medium, persistently add methanol and carry out inducing 4 days.Bacteria recovered by centrifugation,
Wash twice, redissolve with Tris-HCl pH 7.5 buffer of a certain amount of 50mM, add substrate A D and convert, convert
Condition is: conversion temperature is 37 DEG C, and converting pH is 7.5, and substrate cosolvent is methyl-β-cyclodextrin (molar ratio is 1:1),
Biomass is 200g/L, and concentration of substrate is 5g/L.After 3 feed supplement resting cells, 15g/L ANDROSTENEDIONE converts
For 14.3g/L testosterone, build NADPH coenzyme indirect regeneration for domestic and international first passage in Pichia sp., utilize androstane
Alkene diketone production of testosterone by conversion, the final purpose realizing improving conversion rate, efficiently production testosterone.
Claims (5)
1. the 17beta-Hydroxysteroid dehydrogenase gene that a codon optimizes, it is characterised in that its nucleotide sequence such as SEQ ID
Shown in NO.1.
2. a recombiant plasmid pINA1292-17 β-hsd3, it is characterised in that 17 beta-hydroxysteroids described in claim 1 are taken off
Hydrogenase gene is connected acquisition with carrier pINA1292.
3. the structure of a transformation system, it is characterised in that NADP can be catalyzed+The enzyme such as glucose dehydrogenase of synthesis NADPH
GDH is connected the recombiant plasmid pINA1292-17 β-hsd3-GDH that acquisition is new with the recombiant plasmid described in claim 2, and will weight
Group plasmid pINA1292-17 β-hsd3-GDH coexpression in Yarrowia lipolytica Polh obtains.
4. the application of transformation system described in claim 3, it is characterised in that be applied to convert ANDROSTENEDIONE synthesis testosterone.
5. can be catalyzed NADP described in claim 3+The enzyme of synthesis NADPH, it is characterised in that preferably, but be not limited to select
Glucose dehydrogenase.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610575007.5A CN106011158A (en) | 2016-07-20 | 2016-07-20 | Method using microorganism method to convert androstenedione so as to produce testosterone |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610575007.5A CN106011158A (en) | 2016-07-20 | 2016-07-20 | Method using microorganism method to convert androstenedione so as to produce testosterone |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106011158A true CN106011158A (en) | 2016-10-12 |
Family
ID=57116944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610575007.5A Pending CN106011158A (en) | 2016-07-20 | 2016-07-20 | Method using microorganism method to convert androstenedione so as to produce testosterone |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106011158A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108796021A (en) * | 2017-04-28 | 2018-11-13 | 沈阳药科大学 | A kind of engineering bacteria and its purposes for being used to prepare stosterone |
CN109306342A (en) * | 2017-07-26 | 2019-02-05 | 中国科学院天津工业生物技术研究所 | A kind of new 17 beta-hydroxy steroid dehydrogenase types, its gene and application |
CN111471737A (en) * | 2020-04-26 | 2020-07-31 | 江南大学 | Method for preparing sterol derivative by virtue of Burkholderia transformation and application |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1670185A (en) * | 2005-03-03 | 2005-09-21 | 上海来益生物药物研究开发中心有限责任公司 | Mycobacterium fortuitum and its use in production of testosterone by conversion of microbe |
CN102168099A (en) * | 2011-01-21 | 2011-08-31 | 华东理工大学 | 3-ketosteroid -delta 1-dehydrogenase, engineering bacterium and application thereof |
CN103502442A (en) * | 2010-12-16 | 2014-01-08 | 细胞制药有限公司 | Novel 7 Beta-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid |
CN104350157A (en) * | 2012-05-28 | 2015-02-11 | 化学药品与食品产品股份公司 | Process for the selective reduction of bile acids, salts or derivatives thereof, in biphasic system |
-
2016
- 2016-07-20 CN CN201610575007.5A patent/CN106011158A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1670185A (en) * | 2005-03-03 | 2005-09-21 | 上海来益生物药物研究开发中心有限责任公司 | Mycobacterium fortuitum and its use in production of testosterone by conversion of microbe |
CN103502442A (en) * | 2010-12-16 | 2014-01-08 | 细胞制药有限公司 | Novel 7 Beta-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid |
CN105441399A (en) * | 2010-12-16 | 2016-03-30 | 细胞制药有限公司 | Novel 7 Beta-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid |
CN102168099A (en) * | 2011-01-21 | 2011-08-31 | 华东理工大学 | 3-ketosteroid -delta 1-dehydrogenase, engineering bacterium and application thereof |
CN104350157A (en) * | 2012-05-28 | 2015-02-11 | 化学药品与食品产品股份公司 | Process for the selective reduction of bile acids, salts or derivatives thereof, in biphasic system |
Non-Patent Citations (1)
Title |
---|
GEISSLE ET AL: "Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3", 《NATURE GENETICS》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108796021A (en) * | 2017-04-28 | 2018-11-13 | 沈阳药科大学 | A kind of engineering bacteria and its purposes for being used to prepare stosterone |
CN109306342A (en) * | 2017-07-26 | 2019-02-05 | 中国科学院天津工业生物技术研究所 | A kind of new 17 beta-hydroxy steroid dehydrogenase types, its gene and application |
CN109306342B (en) * | 2017-07-26 | 2021-12-10 | 中国科学院天津工业生物技术研究所 | 17 beta-hydroxy steroid dehydrogenase, gene and application thereof |
CN111471737A (en) * | 2020-04-26 | 2020-07-31 | 江南大学 | Method for preparing sterol derivative by virtue of Burkholderia transformation and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3091070B1 (en) | Genetic recombinant saccharomyces cerevisiae capable of degrading and utilizing kitchen wastes | |
CN106011158A (en) | Method using microorganism method to convert androstenedione so as to produce testosterone | |
EP1736548A1 (en) | Use of corn with low gelatinization temperature for production of fermentation-based products | |
CN104531746B (en) | A method of ADD is generated using recombinant C orynebacterium crenatum resting cell AD | |
CN107099516A (en) | 7 β hydroxy sterols dehydrogenase mutants and its application in ursodesoxycholic acid synthesis | |
CN105400796A (en) | Gene for adjusting and controlling production of long-chain diacid and application of gene | |
Han et al. | Consolidated bioprocessing for sodium gluconate production from cellulose using Penicillium oxalicum | |
CN102816825A (en) | Method for preparing dehydroepiandrosterone by microbial fermentation | |
CN111712576B (en) | Microorganism strain and use thereof | |
CN109306342B (en) | 17 beta-hydroxy steroid dehydrogenase, gene and application thereof | |
CN104830888B (en) | A kind of new new gold mycobacteria expression system and its application in transformation phytosterin synthesizes ADD | |
Jack et al. | High rate CO2 valorization to organics via CO mediated silica nanoparticle enhanced fermentation | |
CN103014074B (en) | Production method of high-concentration ethanol with sweet potatoes serving as raw materials | |
Gao et al. | Efficient ethanol production from inulin by two-stage aerate strategy | |
CN106566816A (en) | 3-ketosteroid-[delta]1-dehydrogenase mutant and construction method thereof | |
CN101591233A (en) | The preparation method of gluconic acid | |
CN110343624B (en) | Recombinant strain and application thereof in improving yield of cellulase | |
CN115044603B (en) | Method for regulating and controlling/reducing acetyl coenzyme A branch metabolism to efficiently synthesize 7-dehydrocholesterol | |
CN106191190B (en) | A method of it eliminating hydrogen peroxide and improves androstane diene diketone yield | |
CN105274112A (en) | Promoter in induced expression under acidic condition | |
CN103937842A (en) | Method for increasing yield of alpha-oxoglutarate produced through whole-cell transformation | |
CN101717795A (en) | Method for producing ethanol by applying starch | |
CN103981207B (en) | A kind of method utilizing restructuring Bacillus subtilis resting cell cholesterol to generate cholesteric-4-alkene-3-ketone | |
CN106929530B (en) | A method of yeast cells is improved to composite inhibitor tolerance | |
CN106636160A (en) | Method for generating ADD by converting AD through recombined Escherichia coli whole cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161012 |